Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
10/2003
10/23/2003US20030199550 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/23/2003CA2480415A1 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480410A1 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1140745B1 Colchinol derivatives as vascular damaging agents
10/22/2003EP1071654B1 A process for preparing chiral (s)-2,3-disubstituted-1-propylamine derivatives
10/22/2003EP0994850B1 Inhibition of hiv-1 replication using oligocarbamate derivatives
10/22/2003CN1450989A 7-substituted tetracycline compounds
10/22/2003CN1450051A Amino acid derivatives and their use as pesticides
10/22/2003CN1125061C C2 taxane derivatives and pharmaceutical compositions containing them
10/22/2003CN1125060C C-10 taxane derivatives and pharmaceutical compositions containing them
10/21/2003US6635784 Process for the preparation of enantiomerically-enriched cyclopropylalanine derivates
10/21/2003US6635650 Such as N-(2-(7-(2-((8-(2-(acetyl-amino)ethyl)-2-naphthyl) oxy)ethoxy)-1-napthyl)ethyl)acetamide for treating or preventing melatoninergic disorders
10/21/2003CA2098020C Anti-viral compounds
10/16/2003WO2003070701A3 Syntheses of quinazolinones
10/16/2003WO2003048108A3 Compounds for treatment of inflammation, diabetes and related disorders
10/16/2003WO2003031393A3 Carbonyloxy-cyanomethyl compounds as antiparasitic agents
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2002100347A3 Prodrugs of gaba analogs, compositions and uses thereof
10/16/2003WO2002076939A3 Cysteine protease inhibitors
10/16/2003US20030195365 CC-1065 analog synthesis
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195226 Nitrogen compounds such as pyridine-3-carbaldehyde, O-(((4-undecyloxy-phenyl)amino)carbonyl)oxime, used for prophylaxis of vision, eating or cardiovascular disorders, and as anxiolytic and antiemetic agents
10/16/2003US20030195223 Antithrombotic agents
10/16/2003US20030195206 An enzyme inhibitors, enzyme is to catalyse the hydrolysis of an ester; treating hyperlipaemia, hyperglycaemia (type II diabetes), hypertension, cardiovascular disorders stroke, gastrointestinal disease; chemical intermediate synthesis
10/15/2003EP1352900A1 Process to prepare taxol
10/15/2003EP1352899A1 Process to prepare taxol
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003EP1351941A1 Bisaryl derivatives having fsh receptor modulatory activity
10/15/2003EP1351924A2 Diamines as modulators of chemokine receptor activity
10/15/2003EP1351912A2 Substituted stilbenes, their reactions and anticancer activity
10/15/2003EP0766674B1 New hiv protease inhibitors
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632833 2-(2-methylphenyl)-3,4-dihydro-2H-pyrrole derivatives
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/09/2003WO2003082809A1 Diaminoacid-aminoacid-polyamine based gemini surfactant compounds
10/09/2003WO2003082777A2 Novel glucocorticoid receptor ligands
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003WO2003082190A2 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003WO2003014076A3 Bi-directional synthesis of oligoguanidine transport agents
10/09/2003WO2002083627A3 Ligands des integrins avss6
10/09/2003US20030191123 2-amino-benzoxazinone derivatives for the treatment of obesity
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030190298 Use as skin lightening agents
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/08/2003EP0951284B1 Phenylethylamine derivatives
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1123564C Anti-inflammatory compounds
10/07/2003US6630600 Intermediate for their manufacture, pharmaceutical preparations containing them and the use of the compounds in clinical conditions associated with insulin resistance.
10/07/2003US6630598 Reacting nitroaniline compound with acid chloride/anhydride in presence of alkali metal/earth metal compound
10/07/2003US6630512 Cell adhesion inhibitors
10/07/2003US6630510 Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
10/07/2003US6630509 Phenalkyloxy-phenyl derivatives
10/07/2003CA2251003C New compounds, derivatives of n-aryl 2-hydroxyalkylamides
10/02/2003WO2003079984A2 Substituted tetracycline compounds
10/02/2003WO2002055481A8 Prodrugs of excitatory amino acids
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/01/2003EP1348691A1 Process for producing alpha-aminohalomethyl ketone derivatives
10/01/2003EP1347952A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
10/01/2003EP1084102B1 New 3-aryl propionic acid derivatives and analogs
10/01/2003EP0922037B1 Preparation of fungicidal quinazolinones and useful intermediates
10/01/2003EP0847393B1 Paclitaxel synthesis from precursor compounds and methods of producing the same
10/01/2003CN1446208A Process for preparing discodermolid and analogues thereof
10/01/2003CN1446193A Aminoadamantane derivatives as therapeutic agents
09/2003
09/30/2003US6627763 Compounds having protected hydroxy groups
09/30/2003US6627761 Preparing a carbonate urethane compound, by reacting a hydroxy functional carbonate compound such as glycerin carbonate and a diisocyanate in base and solvent; further reacting with diamine to form curing agent for polyepoxides
09/30/2003US6627645 Muscarinic agonists
09/25/2003WO2003078376A1 Nk1 antagonists
09/25/2003WO2003077902A1 Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2002074733A3 Tryptase-inhibitors
09/25/2003US20030181753 Method for producing amides or esters
09/25/2003US20030181726 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
09/25/2003US20030181723 Preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-P-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
09/25/2003US20030181391 Dipeptide apoptosis inhibitors and the use thereof
09/25/2003US20030181388 Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or entire
09/25/2003CA2478211A1 Nk1 antagonists
09/24/2003EP1346979A1 Processes for preparation of n-protected- -amino alcohols and n-protected- -amino epoxides
09/24/2003EP1346972A1 Process for producing optically active halohydrin compound
09/24/2003EP1346971A1 Production method for biarylalanine
09/24/2003EP1345888A1 Method for the production of 1,5-naphthalenediamine
09/24/2003CN1444504A Process and unit for continuous preparation of isocyanate-containing polyurethane prepolymers
09/24/2003CN1122021C Amino acid derivatives and their use as pesticides
09/24/2003CN1122018C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
09/23/2003US6624279 Curable water-soluble carbamate-functional resins
09/23/2003US6624241 Waterborne coating compositions containing materials dispersed with water-soluble carbamate materials
09/23/2003US6624211 Dental materials with extendable work time, kits, and methods
09/23/2003US6624161 Administering 2-oxy substituted benzoxazin-5-one derivative to a human or animal for the prevention or treatment of obesity or an obesity related disorder
09/23/2003US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases
09/23/2003US6624142 Trimethyl lock based tetrapartate prodrugs
09/23/2003US6624120 Substituted herbicidal phenyluracils
09/23/2003US6624119 3-[Benz(ox/thi)azol-7-yl]-1h-pyrimidine-2,4-diones
09/23/2003US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis
09/23/2003CA2127110C Carbamates and crop protection agents containing them
09/23/2003CA2098122C Anti-atherosclerotic aryl compounds
09/23/2003CA2086654C Novel pharmaceutically active 1,2,4-triaminobenzene derivatives, processes for their preparation and pharmaceutical compositions containing them
09/18/2003WO2003076451A1 Ferrocenyl ligands and the use thereof in catalysis
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076396A1 PROCESS FOR PRODUCING ß-AMINOKETONE AND CATALYST THEREFOR
09/18/2003WO2003076389A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 157